Camelot Portfolios’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11
Closed -$1.07K 260
2025
Q4
$1.07K Buy
+11
New +$1.19K ﹤0.01% 553
2024
Q3
Sell
-104
Closed -$14.2K 219
2024
Q2
$14.2K Buy
+104
New +$14.4K 0.01% 391
2023
Q3
Sell
-1,591
Closed -$253K 147
2023
Q2
$253K Sell
1,591
-106
-6% -$17.1K 0.16% 152
2023
Q1
$269K Sell
1,697
-71
-4% -$10.6K 0.19% 139
2022
Q4
$248K Buy
+1,768
New +$251K 0.18% 145
2022
Q3
Sell
-2,147
Closed -$303K 165
2022
Q2
$303K Buy
+2,147
New +$307K 0.18% 154

Other funds holding CLX

Camelot Portfolios's CLX Position: Q1 2026 in Review

Camelot Portfolios sold out of Clorox (CLX) in Q1 2026, closing a stake of 11 shares — an estimated $1.07K sold.

Camelot Portfolios first reported a position in CLX in Q2 2022 and held it in 6 quarters. The position peaked at $303K in Q2 2022. 1,086 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Camelot Portfolios reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Camelot Portfolios sold 11 Clorox shares in Q1 2026, an estimated $1.07K.
  • Camelot Portfolios first reported a position in Clorox in Q2 2022 and held it in 6 quarters.
  • Camelot Portfolios's Clorox position peaked at $303K in Q2 2022.
  • 1,086 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.